Finns have a unique advantage in their genes, says Marco Hautalahti – It can still spawn an economic miracle worth billions

In Denmark, the pharmaceutical industry boosts and boosts the entire national economy, led by Novo Nordisk. Finland also has tremendous potential in pharmaceutical development, as long as the competitive advantage is not cut short in the government’s austerity talks, says FINBB’s Marco Hautalahti in an interview with KL.

Marco Hautalahti, CEO of the Finnish biobank cooperative FINBB, has recently arrived from a business trip from Boston, USA. Although the time difference